4 mg retatrutide Dosage: Week-to-Week Schedule & Chart VisualAbstract: Retatrutide reduces body weight

This builds on our already comprehensive GLP-1 formulary, and reflects the work across our teams to quickly bring new innovations to patientsexpanding access and giving patients more options to reach their goals

Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction

And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management

GLP-1 Receptor Agonists in Diabetic Kidney Disease: from Clinical Outcomes to Mechanisms

They all activate GLP-1 receptors, and using two GLP-1 agonists simultaneously would increase side effect risk without proportional benefit

Get it right, and the results speak for themselves, with phase 2 trial participants losing an average of 24.2% of their body weight at the 12mg dose over 48 weeks